MRNY vs. ENVB
MRNY (YieldMax MRNA Option Income Strategy ETF) is Derivative Income fund actively managed by YieldMax, while ENVB (Enveric Biosciences Inc) is a stock. Over the past year, MRNY returned 53.54% vs -89.81% for ENVB. At a 0.20 correlation, their price movements are largely independent.
Performance
MRNY vs. ENVB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MRNY achieves a 56.58% return, which is significantly higher than ENVB's -59.23% return.
MRNY
- 1D
- 2.91%
- 1M
- 5.64%
- YTD
- 56.58%
- 6M
- 51.42%
- 1Y
- 53.54%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ENVB
- 1D
- -3.27%
- 1M
- -34.22%
- YTD
- -59.23%
- 6M
- -72.39%
- 1Y
- -89.81%
- 3Y*
- -87.52%
- 5Y*
- -85.10%
- 10Y*
- -74.86%
MRNY vs. ENVB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
MRNY YieldMax MRNA Option Income Strategy ETF | 56.58% | -35.72% | -59.32% | 18.27% |
ENVB Enveric Biosciences Inc | -59.23% | -94.37% | -72.43% | -29.35% |
Correlation
The correlation between MRNY and ENVB is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Oct 24, 2023 | 0.20 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MRNY vs. ENVB — Risk / Return Rank
MRNY
ENVB
MRNY vs. ENVB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for YieldMax MRNA Option Income Strategy ETF (MRNY) and Enveric Biosciences Inc (ENVB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MRNY | ENVB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.59 | ||
| Sortino ratioReturn per unit of downside risk | +2.82 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 0.87 | +0.34 |
| Calmar ratioReturn relative to maximum drawdown | 1.71 | -0.98 | +2.69 |
| Martin ratioReturn relative to average drawdown | 3.30 | -1.34 | +4.65 |
Loading charts...
Drawdowns
MRNY vs. ENVB - Drawdown Comparison
The maximum MRNY drawdown since its inception was -82.15%, smaller than the maximum ENVB drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for MRNY and ENVB.
Loading charts...
Drawdown Indicators
| MRNY | ENVB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -82.15% | -100.00% | +17.85% |
Max Drawdown (1Y)Largest decline over 1 year | -31.53% | -91.49% | +59.96% |
Max Drawdown (3Y)Largest decline over 3 years | — | -99.81% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -100.00% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -100.00% | — |
Current DrawdownCurrent decline from peak | -67.04% | -100.00% | +32.96% |
Average DrawdownAverage peak-to-trough decline | -52.78% | -86.07% | +33.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.25% | 66.73% | -50.48% |
Volatility
MRNY vs. ENVB - Volatility Comparison
The current volatility for YieldMax MRNA Option Income Strategy ETF (MRNY) is 12.97%, while Enveric Biosciences Inc (ENVB) has a volatility of 21.07%. This indicates that MRNY experiences smaller price fluctuations and is considered to be less risky than ENVB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MRNY | ENVB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.97% | 21.07% | -8.10% |
Volatility (6M)Calculated over the trailing 6-month period | 37.72% | 105.59% | -67.87% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.94% | 175.01% | -125.07% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 50.72% | 155.96% | -105.24% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 50.72% | 164.65% | -113.93% |
Dividends
MRNY vs. ENVB - Dividend Comparison
MRNY's dividend yield for the trailing twelve months is around 102.17%, while ENVB has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
ENVB Enveric Biosciences Inc | 0.00% | 0.00% | 0.00% | 0.00% |
MRNY YieldMax MRNA Option Income Strategy ETF | 102.17% | 145.98% | 178.49% | 1.75% |
Frequently Asked Questions
MRNY and ENVB have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ENVB has higher volatility (21.07%) compared to MRNY (12.97%). In terms of maximum drawdown, MRNY dropped -82.15% vs ENVB's -100.00%.
MRNY currently has the higher Sharpe Ratio (1.08 vs -0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MRNY and ENVB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer